pembrolizumab,sotigalimab
merck,apexigen
['pembro', 'sotigalimab', '$apgn', 'apexigen']
$apgn apexigen announces new data from a phase 1/2 trial evaluating its cd40 antibody, sotigalimab, in combination with pembrolizumab in patients with first-line metastatic melanoma at the sitc 2022 annual meeting 